Bought
Maintained
Sold
Other funds holding MDT
VCM
VPM
Amundi's MDT Position: Q1 2026 in Review
Amundi increased its Medtronic (MDT) stake by 36% in Q1 2026, buying an estimated $155M and bringing the position to 6,070,236 shares worth $526M. The position accounts for 0.14% of the portfolio, ranked #132.
Amundi first reported a position in MDT in Q2 2021 and has held it in 20 quarters since. The position peaked at $921M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Amundi held 6,070,236 shares of Medtronic worth $526M as of Q1 2026.
- Amundi bought 1,616,739 Medtronic shares in Q1 2026, an estimated $155M.
- Medtronic made up 0.14% of Amundi's portfolio in Q1 2026, its #132 holding.
- Amundi first reported a position in Medtronic in Q2 2021 and has held it in 20 quarters since.
- Amundi's Medtronic position peaked at $921M in Q2 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.